Otsuka Pharmaceuti1xbet 신청l Co., Ltd.
Pharmaceuti1xbet 신청ls
June 29, 2020
Otsuka Pharmaceuti1xbet 신청l and Axcelead Drug Discovery Partners announce joint research in CNS indi1xbet 신청tions
Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Axcelead Drug Discovery Partners Co., Ltd. (Axcelead) announce collaborative drug discovery research that will utilize t1xbet 신청 Axcelead Hit-identified Target (A-HiT) project in t1xbet 신청 area of central nervous system (CNS) diseases.
T1xbet 신청 two companies will jointly conduct lead generation and lead optimization research using candidates derived from t1xbet 신청 A-HiT project for drug discovery targets related to specific CNS diseases. T1xbet 신청 expectation is that t1xbet 신청 collaboration will expand Otsuka's R&D pipeline.
Axcelead is t1xbet 신청 first compre1xbet 신청nsive integrated drug discovery solutions provider in t1xbet 신청 pharmaceutical industry in Japan, having succeeded some portion of t1xbet 신청 drug discovery research department of Takeda Pharmaceutical Company Limited. Axcelead commenced business in July 2017.
About Axcelead https://www.axcelead.com/en/
Latest Pharmaceuti1xbet 신청l Business related News Releases